Delve into the field of severe epilepsies as new treatments for Dravet syndrome are progressing through the pipeline.

Discover top biotech associations that drive industry growth through collaboration, networking, and strategic partnerships ...

Take a look at six multiple sclerosis companies trying to make a difference to patients by advancing new treatments for the CNS disease.

RNA editing has picked up steam in recent years as a potentially safer alternative to gene editing to treat genetic diseases.

On a mission to overcome the dosing challenges posed by radiotherapy, French nanotherapy company Nanobiotix is developing a ...

As Shift Bioscience raises $16 million in seed funding, delve into the field of cellular reprogramming to tackle age-related ...